MannKind Corporation
USD4.05
+0.07 (+1.76%)
CEO
Michael E. Castagna
IPO Date
2004-07-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.96
Prev. Close
$3.98
Day Low
$3.96
Day High
$4.23
52W Low
$2.23
52W High
$6.51
Market Cap
$1.25B
Volume
4.30M
| 10,675 |
| $4.09 |
| 17 Jul 2026 | Marasco Dominic | Pres, Endocrine Business Unit | F-InKind | Disposed | 3,623 | $4.09 |
| 17 Jul 2026 | Tross Stuart A | Chief People & Workpl Officer | M-Exempt | Acquired | 93,790 | $0.00 |
| 17 Jul 2026 | Tross Stuart A | Chief People & Workpl Officer | F-InKind | Disposed | 33,652 | $4.09 |
| 17 Jul 2026 | Tross Stuart A | Chief People & Workpl Officer | F-InKind | Disposed | 8,253 | $4.09 |
| 17 Jul 2026 | Tross Stuart A | Chief People & Workpl Officer | F-InKind | Disposed | 11,572 | $4.09 |
| 17 Jul 2026 | Tross Stuart A | Chief People & Workpl Officer | F-InKind | Disposed | 12,331 | $4.09 |
| 17 Jul 2026 | Tross Stuart A | Chief People & Workpl Officer | M-Exempt | Disposed | 93,790 | $0.00 |
| 17 Jul 2026 | Castagna Michael | director, officer: Chief Executive Officer | M-Exempt | Acquired | 350,260 | $0.00 |